Syntone Ventures LLC 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-17 9:38 pm Purchase | 2024-04-15 | 13D | Outlook Therapeutics, Inc. OTLK | Syntone Ventures LLC | 2,776,867 11.400% | 2,776,867 (New Position) | Filing |